Background: Cockroft-Gault (CG) and Modification of Diet in Renal Disease (MDRD) formulae have not been validated in critically ill Indian patients. We sought to quantify the discrepancy, if any, in Glomerular Filteration Rate (GFR) estimated by CG and MDRD formulae with 24 hrs urine Creatinine Clearance (Cr Cl). Materials and Methods: Prospective cohort study in 50 adult patients in a mixed medical-surgical intensive care unit. Inclusion criteria: Intensive Therapy Unit (ITU) stay >48 hrs and indwelling urinary catheter. Exclusion criteria: Age <18 years, pregnancy, dialysis, urine output <400 ml/day and patients receiving ranitidine, cefoxitin, trimethoprim or diuretics. We estimated Creatinine Clearance by CG and MDRD formula and measured GFR by 24 hrs urine creatinine clearance. Bland Altman plot was used to find the difference between the paired observations. The association between the methods was measured by the product moment correlation coefficient. Result: The mean GFR as calculated by Creatinine Clearance was 79.76 ml/min/1.73 m 2 [95% Confidence Interval (CI) 65.79 to 93.72], that by CG formula was 90.05 ml/min/1.73 m 2 [95% CI: 74.50 to 105.60], by MDRD was 85.92 ml/min/1.73 m 2 [95% CI: 71.25 to 100.59]. The Bias and Precision between CG and Cr Cl were -4.5 and 140.24 respectively, between MDRD and Cr Cl was -6.1 and 122.52. The Correlation coefficient of CG formula as a measure of GFR was 0.65 ( P < 0.0001), that of MDRD was 0.70 ( P < 0.0001). Conclusion: We conclude that CG and MDRD formulae have a strong correlation with measured GFR but are not a reliable measure and overestimate GFR in critically ill Indian patients.
Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, et al. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005;20:747-53.
Kasiske BL, Keane WF. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy, in Brenner and Rector′s The Kidney. 6 th ed. Philadelphia, PA: W.B. Saunders; 2000. p. 1129-70.
Hsu CY, Chertow GM, Curhan GC. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 2002;61:1567-76.
Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
Wilson RF, Soulilier G. The validity of two hour creatinine clearance studies in critically ill patients. Crit Care Med 1980;8:281-4.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
Cherry RA, Eachempati SR, Hydo L, Barie PS. Accuracy of short-duration creatinine clearance determinations in predicting 24-hour creatinine clearance in critically ill and injured patients. J Trauma 2002;53:267-71.
Evans W, Lensmeyer JP, Kirby RS, Malnory ME, Broekhuizen FF. Two-hour urine collection for evaluating renal function correlates with 24-hour urine collection in pregnant patients. J Matern Fetal Med 2000;9:233-7.
Pesola GR, Akhavan I, Madu A, Shah NK, Carlon GC. Prediction equation estimates of creatinine clearance in the intensive care unit. Intensive Care Med 1993;19:39-43.
Du Bois D, Du Bois EF. A formula to estimate the approx surface area if height and weight be known. Arch Intern Med 1916;17:863-71.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
Hailemeskel B, Namanny MD, Kurz A. Estimating aminoglycoside dosage requirements in patients with low serum creatinine concentrations. Am J Health Syst Pharm 1997;54:986-7.
Leader WG, Tsubaki T, Chandler MH. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients. Am J Hosp Pharm 1994;51:2125-30.
Beck GJ, Berg RL, Coggins CH, Gassman JJ, Hunsicker LG, Schluchter MD, et al. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials 1991;12:566-86.
Kusek JW, Coyne T, de Velasco A, Drabik MJ, Finlay RA, Gassman JJ, et al. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Control Clin Trials 1993;14:538-57.
Villa P, Jiménez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005;9:R139-43.
Herget-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A. Cystatin C: Efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 2000;20:97-102.
Jung K, Jung M. Cystatin C: A promising marker of glomerular filtration rate to replace creatinine. Nephron 1995;70:370-1.
Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000;37:49-59.
Wulkan R, den Hollander J, Berghout A. Cystatin C: Unsuited to use as a marker of kidney function in the intensive care unit. Crit Care 2005;9:531-2.